Onco-Innovations Limited
ONCO
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 79.90K | 110.50K | 133.50K | 83.10K | 68.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.90K | 110.50K | 133.50K | 83.10K | 68.90K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 79.90K | 110.50K | 110.50K | 60.10K | 45.90K |
| SG&A Expenses | 4.56M | 4.78M | 4.26M | 2.35M | 2.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.49M | 5.56M | 4.89M | 2.68M | 2.19M |
| Operating Income | -5.41M | -5.45M | -4.78M | -2.62M | -2.14M |
| Income Before Tax | -7.85M | -10.07M | -9.50M | -7.03M | -5.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.85 | -10.07 | -9.50 | -7.03 | -5.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.85M | -10.07M | -9.50M | -7.03M | -5.33M |
| EBIT | -5.41M | -5.45M | -4.78M | -2.62M | -2.14M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.14 | -0.19 | -0.19 | -0.15 | -0.12 |
| Normalized Basic EPS | -0.09 | -0.10 | -0.10 | -0.07 | -0.05 |
| EPS Diluted | -0.14 | -0.19 | -0.19 | -0.15 | -0.12 |
| Normalized Diluted EPS | -0.09 | -0.10 | -0.10 | -0.07 | -0.05 |
| Average Basic Shares Outstanding | 221.87M | 212.28M | 195.46M | 179.51M | 160.61M |
| Average Diluted Shares Outstanding | 221.87M | 212.28M | 195.46M | 179.51M | 160.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |